Polypox A/S: Financial statements 2024
CVR: 40683321
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Polypox A/S (CVR 40683321) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,950,557 and a net result of DKK 1,401,234 compared with DKK 899,434 the year before. That is an increase of 51.5% compared with the year before. Equity in the 2024 report amounted to DKK 2,476,477. The solvency ratio was 52.2%.
- Gross Profit
- DKK 1,950,557
- Profit/Loss
- DKK 1,401,234
- Equity
- DKK 2,476,477
- Total Assets
- DKK 4,747,294
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2 mio. | 1.4 mio. | 2.5 mio. | 0 |
| 2023 | - | 1.3 mio. | 899 t. | 1.9 mio. | 0 |
| 2022 | - | 791 t. | 494 t. | 2.3 mio. | - |
| 2021 | - | 1.8 mio. | 1.3 mio. | 2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Polypox A/S has published its annual report for 2023. Gross profit came to DKK 1,287,902, and the net result was DKK 899,434.
As of June 25, 2024, Martin Jensen has joined the board of directors of Polypox A/S.
About Polypox A/S
Polypox A/S is a Danish company of the type Aktieselskab based in Videbæk, founded in 2019. The company is registered under the industry Udførelse af gulvbelægninger og vægbeklædning. The management consists of Christian Grønbæk Jensen. The board consists of Martin Jensen (chair), Christian Grønbæk Jensen and Preben Sundgård Laugesen. The company's owners include FLORIDANES A/S, Møllemarken Holding ApS and Jensen & Knipchildt Holding ApS. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 7,611,054 and a net result of DKK 2,389,508 compared with DKK 1,401,234 the year before. Equity in the 2025 report amounted to DKK 3,465,985.